Immunotherapy uses a person's own immune system to fight cancer. Immune checkpoint inhibitors are one class of immunotherapy ...

Clinical data builds with CR in testicular cancer, enrollment in Phase 2 gastric trial, and new data in PD-1–resistant tumors ...

BrainChild Bio, Inc., a clinical-stage biotechnology company developing CAR T-cell therapies to treat tumors in the central nervous system (CNS), today announced that the investigational B7-H3 ...

According to Gartner’s Magic Quadrant, Check Point is the leader in email security platforms. Today email is still ...

During a live event, Pedro C. Barata, MD, MSc, discussed the case of a patient with advanced clear cell renal cell carcinoma who requires second-line therapy.

Chugai Pharma seeks Japanese additional indication approval for Tecentriq to treat thymic carcinoma: Tokyo Thursday, May 15, 2025, 12:00 Hrs [IST] Chugai Pharmaceutical Co., Ltd., ...

Immunoengineering, which has been beneficial to other medical specialties, could be used in the infectious diseases field to ...

In a new study published in Nature, researchers at the University of Chicago Medicine Comprehensive Cancer Center explore a ...

Fastly, Inc. , a leader in global edge cloud platforms, today announced the appointments of Albert Thong as Chief Marketing Officer and Tara Seracka as Chief Legal Officer. "I am excited to welcome ...

PDS Biotechnology Corporation (NASDAQ: PDSB) Q1 2025 Earnings Call Transcript May 14, 2025 PDS Biotechnology Corporation ...

Given it's National Palliative Care Week, it’s apt that two drug developers have posted hopeful trial updates pertaining to ...